Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Method and apparatus for detecting an intermittent path to a storage system
Specification of latency in programmable device configuration
Method for modeling and analyzing linear time invariant systems with time delays
Color variation control process for molding plastic and composite multi-color articles
Visually tracking an object in real world using 2D appearance and multicue depth estimations
Method for mapping resource units
Drug comprising as the active ingredient proliferative vector containing survivin promoter
  Randomly Featured Patents
Apparatus and method for synchronizing nonlinear systems using filtered signals
Biomass conversion process
Fuel spacer
Two handled controller for a locomotive
Pen with an improved ink injection system
Antenna array having sliding dielectric phase shifters
Automated safestore stack generation and recovery in a fault tolerant central processor
Circuit arrangement for detecting the state of at least one electrical switch
Webpage request handling